Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Micardis telmisartan: Phase IV started

BAY's Bayer Schering Pharma AG unit began the double-blind, European Phase IV TALENT trial in

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE